| ID: | 120 | |
|---|---|---|
| Name: | Compound 120 | |
| Description: | Original numeration in publication: 11c | |
| Labels: | Training_set, Benzylquinazoline | |
| CAS: | ||
| InChi Code: | InChI=1S/C31H23Cl2N5O4/c32-23-13-10-22(26(33)16-23)17-34-36-29(40)21-11-14-24(15-12-21)35-28(39)19-38-30(41)25-8-4-5-9-27(25)37(31(38)42)18-20-6-2-1-3-7-20/h1-17H,18-19H2,(H,35,39)(H,36,40)/b34-17+ |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 6.89 |
El-Adl, K.; El-Helby, A.-G. A.; Sakr, H. a. E.-H., S. S. A. Design, synthesis, molecular docking, and anticancer evaluations of 1-benzylquinazoline-2,4(1H,3H)-dione bearing different moieties as VEGFR-2 inhibitors. Arch. Pharm. (Weinheim) 2020, 353, e2000068. https://doi.org/10.1002/ardp.202000068 |
| 6.22303 |
Eq1: VEGFR-2 inhibition (Data used to train model) |